Atrial Sensing Capability for Better Detection of Atrial Fibrillation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

640 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-01

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective multi-center randomized controlled study aims to compare atrial fibrillation detection and inappropriate therapy according to activation of atrial sensing capability in patients with implantable cardioverter defibrillator.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

NCT02186704

Atrial Fibrillation

COMPLETED

Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)

NCT04397224

Heart Failure

UNKNOWN

Remote ECG Monitoring of TAVI Patients

NCT03810820

Cardiac Valve Disease Aortic Valve Stenosis

UNKNOWN NA

A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic

NCT00606567

Tachycardia, Ventricular Ventricular Fibrillation

COMPLETED NA

Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.

NCT04869527

Arrhythmias, Cardiac

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Implantable cardioverter defibrillators(ICD) therapy has been shown to reduce sudden cardiac death and improve survival in cardiac arrest survivors as well as in heart failure patients with left ventricular dysfunction.

Atrial fibrillation (AF) is commonly found in ICD implantation patients up to 50%. AF is an independent predictor of mortality, inappropriate shock, and embolic events. Therefore, early detection of AF in patients with ICD is essential for improving the quality of life and overall prognosis of the patients.

Conventional ICDs consist of a single chamber (SC) ICD with a lead only in the right ventricle (RV) and dual chamber (DC) ICD with each lead in the right atrium (RA) and RV. SC ICD has the advantage of shorter procedure time, lower cost compared to DC ICD. In contrast, DC ICD has the advantage of being able to monitor atrial arrhythmic events, but complication rates were higher and additional cost and longer procedure time are usually required than SC ICD. Sixty percent of ICD implantation patients who have are SC ICD Recently, a unique ICD lead with atrial sensing ring capable of monitoring the atrial electrical signals has been developed \[Intica 7 VR-T DX ICD (Biotronik., Germany)\]. Therefore, turning off the atrial sensing function makes it functionally the same as SC ICD whereas turning on makes it function similar to DC ICD without additional cost and procedure time.

Therefore, Detection of AF could be made earlier with VDD ICD versus conventional SC ICD without atrial sensing capability, providing a better chance to improve the prognosis of ICD patients. However, no study exists which shows whether VDD ICD is better for detecting atrial tachyarrhythmia than conventional SC ICD. Therefore, we designed a multicenter prospective randomized study comparing the AF diagnostic efficacy of VDD ICD (with atrial sensing 'ON') against conventional SC ICD. As the second phase, we also plan to compare inappropriate therapy rate according to atrial sensing status of VDD ICD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implantable Cardioverter Defibrillator Atrial Fibrillation Cardiac Event Cardiac Arrhythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients are randomly assigned as atrial sensing ON or Off mode

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Atrial sensing OFF mode

VDD-ICD programmed as atrial sensing Off mode

Group Type NO_INTERVENTION

No interventions assigned to this group

Atrial sensing ON mode

VDD-ICD programmed as atrial sensing ON mode

Group Type ACTIVE_COMPARATOR

Atrial sensing On mode

Intervention Type DEVICE

Single lead VDD-ICD programmed as atrial sensing On mode.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Atrial sensing On mode

Single lead VDD-ICD programmed as atrial sensing On mode.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age ≥ 19 years
2. indication for ICD implantation according to guidelines
3. atrial fibrillation didn't detect by electrocardiogram or Holter test within the past 1 year from the ICD implantation, and
4. CHA2DS2VASc score ≥1 point in male or ≥ 2 in female

Exclusion Criteria

1. persistent or permanent atrial fibrillation (AF)
2. atrial fibrillation detected by electrocardiogram or Holter test within the past 1 year from the ICD implantation
3. history of the catheter or surgical ablation of AF or taking antiarrhythmic drug
4. scheduled to undergo heart transplant within 1 year
5. life expectancy \< 1 year
6. requiring atrial pacing

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No